Wellspect is in the process of converting its product documentation - the Technical files - to meet the new EU Regulation for Medical Devices. This regulation replaces the earlier directive, leaving no room for ambiguous interpretation.
Wellspect products are manufactured to the highest standards, and users and healthcare professionals are involved with the development of these products from the beginning. Feedback, clinical studies and consultation are crucial in creating these essential products for our users, and for an enduring quality of life.
We spoke with Christoph Kimling, Wellspect's Marketing Manager for the DACH region, about the impact of our latest sustainability initiatives for our partners, users and organization.
Samhall is a government-funded organization that trains and matches people with disabilities to the right job. This is a sustainable business concept, and one that has seen Samhall named the most sustainable company in Europe. Samhall is working with companies that share their values on diversity in the labor market. For more than 20 years, Wellspect has enjoyed a collaboration with Samhall, with nearly 200 Samhall employees working at Wellspect’s production site in Mölndal, Sweden.
We know that the production, transportation, and disposal of our products has an environmental impact and generates a significant amount of greenhouse gas emissions, which contribute to climate change. By working actively to reduce our climate impact, while also making sure we adapt to the existing medical guidelines, we are prepared to take on the challenge of developing a future climate-neutral product.